Conclusions made by a group of experts from academia and industry More: New pricing models could improve access to innovative cancer drugs Source: News
read moreNovo Nordisk lays out $1.8B for Emisphere and its oral delivery tech fkansteiner Fri, 11/06/2020 – 11:12 More: Novo Nordisk lays out .8B for Emisphere and its oral delivery tech Source: fierce
read moreEli Lilly bids farewell to longtime digital chief Aarti Shah bbulik Fri, 11/06/2020 – 10:50 More: Eli Lilly bids farewell to longtime digital chief Aarti Shah Source: fierce
read moreAstraZeneca’s Brilinta won its coveted stroke-prevention nod. Will it be enough to boost long-term sales? aliu Fri, 11/06/2020 – 09:45 More: AstraZeneca's Brilinta won its coveted stroke-prevention nod. Will it be enough to boost long-term sales? Source: fierce
read moreRegeneron predicts 300,000 COVID-19 cocktail doses ready by January, and ‘substantially more’ in 2021 esagonowsky Fri, 11/06/2020 – 09:26 More: Regeneron predicts 300,000 COVID-19 cocktail doses ready by January, and 'substantially more' in 2021 Source: fierce
read moreFiercePharmaAsia—AstraZeneca’s China slowdown; Novartis’ Asia CAR-T site; Clover’s COVID-19 funding aliu Fri, 11/06/2020 – 07:45 More: FiercePharmaAsia—AstraZeneca's China slowdown; Novartis' Asia CAR-T site; Clover's COVID-19 funding Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals